The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 120, 251-261
Abstract
No abstract availableKeywords
Funding Information
- King Saud University (RG-1438-019)
This publication has 70 references indexed in Scilit:
- A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s diseaseNeuroscience, 2013
- Modeling an autism risk factor in mice leads to permanent immune dysregulationProceedings of the National Academy of Sciences, 2012
- PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-κB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathwayFree Radical Biology and Medicine, 2012
- The role of immune dysfunction in the pathophysiology of autismBrain, Behavior, and Immunity, 2012
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2011
- Peroxisome proliferator–activated receptor δ limits the expansion of pathogenic Th cells during central nervous system autoimmunityJournal of Experimental Medicine, 2010
- Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEPNeuropsychopharmacology, 2009
- Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disordersJournal of Neuroimmunology, 2009
- Altered gene expression and function of peripheral blood natural killer cells in children with autismBrain, Behavior, and Immunity, 2009
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγtNature Immunology, 2008